These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 11153663
1. Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users. Carbone J, Gil J, Benito JM, Navarro J, Muñóz-Fernández A, Bartolomé J, Zabay JM, López F, Fernández-Cruz E. AIDS; 2000 Dec 22; 14(18):2823-9. PubMed ID: 11153663 [Abstract] [Full Text] [Related]
2. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R. J Acquir Immune Defic Syndr (1988); 1993 Aug 22; 6(8):904-12. PubMed ID: 7686224 [Abstract] [Full Text] [Related]
3. CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens. Echaniz P, Arrizabalaga J, Iribarren JA, Cuadrado E. Cell Immunol; 1993 Aug 22; 150(1):72-80. PubMed ID: 7688270 [Abstract] [Full Text] [Related]
4. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. Bouscarat F, Levacher-Clergeot M, Dazza MC, Strauss KW, Girard PM, Ruggeri C, Sinet M. AIDS Res Hum Retroviruses; 1996 Jan 01; 12(1):17-24. PubMed ID: 8825614 [Abstract] [Full Text] [Related]
5. Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection. Lieberman J, Trimble LA, Friedman RS, Lisziewicz J, Lori F, Shankar P, Jessen H. AIDS; 1999 May 28; 13(8):891-9. PubMed ID: 10371169 [Abstract] [Full Text] [Related]
7. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection. Kaufmann GR, Zaunders JJ, Cunningham P, Kelleher AD, Grey P, Smith D, Carr A, Cooper DA. AIDS; 2000 Dec 01; 14(17):2643-51. PubMed ID: 11125882 [Abstract] [Full Text] [Related]
8. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection? Arduino JM, Fischl MA, Stanley K, Collier AC, Spiegelman D. AIDS Res Hum Retroviruses; 2001 Aug 10; 17(12):1099-105. PubMed ID: 11522179 [Abstract] [Full Text] [Related]
10. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers. Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF. Clin Immunol; 2001 Feb 10; 98(2):212-9. PubMed ID: 11161977 [Abstract] [Full Text] [Related]
11. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H. JAMA; 1998 Jan 07; 279(1):35-40. PubMed ID: 9424041 [Abstract] [Full Text] [Related]
12. [T-lymphocyte immune in HIV-infected people and AIDS patients in China]. Li T, Qiu Z, Wang A, Sheng R. Zhonghua Yi Xue Za Zhi; 2002 Oct 25; 82(20):1391-5. PubMed ID: 12509921 [Abstract] [Full Text] [Related]
13. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy. d'Ettorre G, Ceccarelli G, Serafino S, Giustini N, Cavallari EN, Bianchi L, Pavone P, Bellelli V, Turriziani O, Antonelli G, Stroffolini T, Vullo V. J Med Virol; 2016 Aug 25; 88(8):1347-56. PubMed ID: 26765625 [Abstract] [Full Text] [Related]
14. Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years. Arnó A, Ruiz L, Juan M, Zayat MK, Puig T, Balagué M, Romeu J, Pujol R, O'Brien WA, Clotet B. AIDS; 1998 May 07; 12(7):697-704. PubMed ID: 9619800 [Abstract] [Full Text] [Related]
15. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience. Gray CM, Schapiro JM, Winters MA, Merigan TC. AIDS Res Hum Retroviruses; 1998 May 01; 14(7):561-9. PubMed ID: 9591710 [Abstract] [Full Text] [Related]
16. Elevated levels of CD4+CD7- T cells in HIV infection add to the prognostic value of low CD4 T cell levels and HIV-1-RNA quantification. Carbone J, Gil J, Benito JM, Muñóz-Fernández A, Fernández-Cruz E. AIDS; 2001 Dec 07; 15(18):2459-60. PubMed ID: 11774834 [No Abstract] [Full Text] [Related]
17. CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. Mocroft A, Bofill M, Lipman M, Medina E, Borthwick N, Timms A, Batista L, Winter M, Sabin CA, Johnson M, Lee CA, Phillips A, Janossy G. J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb 01; 14(2):158-62. PubMed ID: 9052725 [Abstract] [Full Text] [Related]
18. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection. Giorgi JV, Majchrowicz MA, Johnson TD, Hultin P, Matud J, Detels R. AIDS; 1998 Oct 01; 12(14):1833-44. PubMed ID: 9792384 [Abstract] [Full Text] [Related]
19. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users. Alcabes P, Selwyn PA, Davenny K, Hartel D, Buono D, Schoenbaum EE, Klein RS, Friedland GH. AIDS; 1994 Jan 01; 8(1):107-15. PubMed ID: 7912083 [Abstract] [Full Text] [Related]
20. Increased proliferation within T lymphocyte subsets of HIV-infected adolescents. Starr SE, Sarr M, Campbell DE, Wilson CM, Douglas SD. AIDS Res Hum Retroviruses; 2002 Nov 20; 18(17):1301-10. PubMed ID: 12487818 [Abstract] [Full Text] [Related] Page: [Next] [New Search]